SCHEMBL5265523

SCHEMBL5265523

COc1ccc(-n2nc(C(=O)N3CCC(F)CC3)cc2-c2cnc(NC(=O)OC(C)(C)C)cn2)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 3/20 0.39
GPR119 Q8TDV5 1/20 0.38
HPGD P15428 1/20 0.37
MGLL Q99685 3/20 0.37
PIK3CD O00329 2/20 0.36
PTGS2 P35354 4/20 0.36
MMP13 P45452 1/20 0.35
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35
PTK2 Q05397 1/20 0.35
LMNA P02545 1/20 0.34
SCN9A Q15858 1/20 0.34
PDK2 Q15119 1/20 0.34
PTGS1 P23219 1/20 0.34
EPHX2 P34913 1/20 0.34
PIK3CA P42336 2/20 0.33
PRKAA2 P54646 1/20 0.33
PIK3R2 O00459 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5266607 0.93 CFTR (0.39) CFTRGPR119MGLLPIK3CDMMP13
SCHEMBL5267493 0.92 PTGS2 (0.43) MGLLPIK3CDPTGS2LMNAPIK3CA
SCHEMBL5268146 0.91 HPGD (0.39) CFTRGPR119HPGDMGLLPIK3CD
SCHEMBL5268263 0.91 MGLL (0.40) CFTRGPR119MGLLPIK3CDPTGS2
SCHEMBL5267961 0.85 RPA1 (0.39)
SCHEMBL5270816 0.83 PTGS2 (0.42) HPGDMGLLPTGS2PTGS1EPHX2
SCHEMBL5266652 0.82 CA9 (0.38) MGLL
SCHEMBL5523473 0.81 FAAH (0.35) GPR119PDK2
SCHEMBL5266594 0.81 PTGS2 (0.48) GPR119HPGDMGLLPIK3CDPTGS2
SCHEMBL5526891 0.80 PTK2B (0.33) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070254881-A1 Pyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-11-01 US disclosed
EP-1785418-A1 PYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-05-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254881-A1 Pyrazole Derivative PTGER1, PTGS1, PTGER2 CFTR 2625/4885GPR119 2151/4885HPGD 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.